603367 辰欣药业
已收盘 05-15 15:00:00
资讯
新帖
简况
每周股票复盘：辰欣药业（603367）将参加投资者网上集体接待日活动
证券之星 · 02:21
每周股票复盘：辰欣药业（603367）将参加投资者网上集体接待日活动
辰欣药业（603367）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.77%
证券之星 · 05-13
辰欣药业（603367）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.77%
辰欣药业（603367）披露2025年年度股东会决议公告，5月8日股价下跌0.06%
证券之星 · 05-08
辰欣药业（603367）披露2025年年度股东会决议公告，5月8日股价下跌0.06%
每周股票复盘：辰欣药业（603367）股东户数下降6.82%，一季报净利降8.92%
证券之星 · 05-02
每周股票复盘：辰欣药业（603367）股东户数下降6.82%，一季报净利降8.92%
辰欣药业（603367）2026年一季报简析：净利润同比下降8.92%
证券之星 · 04-30
辰欣药业（603367）2026年一季报简析：净利润同比下降8.92%
辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%
智通财经 · 04-28
辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%
每周股票复盘：辰欣药业（603367）股东减持136.83万股完成
证券之星 · 04-19
每周股票复盘：辰欣药业（603367）股东减持136.83万股完成
辰欣药业（603367）披露股东减持计划实施完毕公告，4月16日股价下跌0.37%
证券之星 · 04-16
辰欣药业（603367）披露股东减持计划实施完毕公告，4月16日股价下跌0.37%
4月15日辰欣药业发布公告，股东减持136.83万股
证券之星 · 04-15
4月15日辰欣药业发布公告，股东减持136.83万股
辰欣药业（603367）2025年年报简析：净利润同比下降17.22%
证券之星 · 04-04
辰欣药业（603367）2025年年报简析：净利润同比下降17.22%
辰欣药业最新公告：2025年度净利润4.21亿元同比下降17.22%
证券之星 · 04-02
辰欣药业最新公告：2025年度净利润4.21亿元同比下降17.22%
股市必读：辰欣药业（603367）3月23日收盘跌5.52%，主力净流出565.56万元
证券之星 · 03-24
股市必读：辰欣药业（603367）3月23日收盘跌5.52%，主力净流出565.56万元
辰欣药业（603367）披露股东减持股份计划公告，3月16日股价下跌0.53%
证券之星 · 03-16
辰欣药业（603367）披露股东减持股份计划公告，3月16日股价下跌0.53%
每周股票复盘：辰欣药业（603367）股东拟减持不超1%股份
证券之星 · 03-15
每周股票复盘：辰欣药业（603367）股东拟减持不超1%股份
辰欣药业最新公告：股东江苏辰昕拟减持不超1%股份
证券之星 · 03-13
辰欣药业最新公告：股东江苏辰昕拟减持不超1%股份
辰欣药业（603367）披露关于股东股份解除质押的公告，1月8日股价上涨0.88%
证券之星 · 01-08
辰欣药业（603367）披露关于股东股份解除质押的公告，1月8日股价上涨0.88%
1月5日辰欣药业涨5.14%，富国新活力灵活配置混合A基金重仓该股
证券之星 · 01-05
1月5日辰欣药业涨5.14%，富国新活力灵活配置混合A基金重仓该股
11月24日辰欣药业现5笔大宗交易 机构净买入2997.52万元
证券之星 · 2025-11-24
11月24日辰欣药业现5笔大宗交易 机构净买入2997.52万元
每周股票复盘：辰欣药业（603367）股东一致行动人更名不涉股权变动
证券之星 · 2025-11-23
每周股票复盘：辰欣药业（603367）股东一致行动人更名不涉股权变动
11月20日辰欣药业创60日新低，富国新活力灵活配置混合A基金重仓该股
证券之星 · 2025-11-20
11月20日辰欣药业创60日新低，富国新活力灵活配置混合A基金重仓该股
暂无数据
公司概况
公司名称：
辰欣药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-09-29
主营业务：
辰欣药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是大容量注射剂、小容量注射剂、口服固体制剂、冻干粉针剂、冲洗剂、滴剂、膏剂、原料（自产外销）。公司是中国化学制药工业百强企业和山东省首批“十强”产业集群领军企业。
发行价格：
11.66
{"stockData":{"symbol":"603367","market":"SH","secType":"STK","nameCN":"辰欣药业","latestPrice":14.82,"timestamp":1778828401000,"preClose":15.15,"halted":0,"volume":9253900,"delay":0,"changeRate":-0.0218,"floatShares":453000000,"shares":453000000,"eps":0.9022,"marketStatus":"已收盘","change":-0.33,"latestTime":"05-15 15:00:00","open":15.1,"high":15.19,"low":14.78,"amount":139000000,"amplitude":0.0271,"askPrice":14.83,"askSize":254,"bidPrice":14.82,"bidSize":528,"shortable":0,"etf":0,"ttmEps":0.9022,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":15.15,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":16.67,"lowLimit":13.64,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":452754129,"isCdr":false,"pbRate":1.06,"roa":"--","peRate":16.426513,"roe":"2.09%","epsLYR":0.93,"committee":0.456512,"marketValue":6710000000,"turnoverRate":0.0204,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-18。","floatMarketCap":6710000000},"requestUrl":"/m/hq/s/603367/tweets","defaultTab":"tweets","newsList":[{"id":"2636061457","title":"每周股票复盘：辰欣药业（603367）将参加投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636061457?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:21","pubTimestamp":1778955669,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，辰欣药业报收于14.82元，较上周的15.67元下跌5.42%。本周，辰欣药业5月11日盘中最高价报15.93元。辰欣药业当前最新总市值67.1亿元，在化学制药板块市值排名81/150，在两市A股市值排名2852/5203。本周关注点来自公司公告汇总：辰欣药业将参加2026年5月15日举行的山东辖区上市公司投资者网上集体接待日活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635420017","title":"辰欣药业（603367）披露将参加2026年山东辖区上市公司投资者网上集体接待日活动，5月13日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635420017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635420017?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:57","pubTimestamp":1778666225,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，辰欣药业报收于15.42元，较前一交易日下跌0.77%，最新总市值为69.81亿元。辰欣药业股份有限公司近日发布《关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告》。公告显示，公司将于2026年5月15日15:00-16:30通过网络远程方式参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2026年山东辖区上市公司投资者网上集体接待日活动”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431374","title":"辰欣药业（603367）披露2025年年度股东会决议公告，5月8日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633431374?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:38","pubTimestamp":1778233137,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，辰欣药业报收于15.67元，较前一交易日下跌0.06%，最新总市值为70.95亿元。该股当日开盘15.68元，最高15.75元，最低15.58元，成交额达7081.4万元，换手率为1.0%。辰欣药业股份有限公司于近日披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月7日召开2025年年度股东会，出席会议的股东及代理人共400人，代表有表决权股份224,470,571股，占公司总股本的49.5789%。所有议案均获通过，无否决议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632284436","title":"每周股票复盘：辰欣药业（603367）股东户数下降6.82%，一季报净利降8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632284436","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632284436?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:31","pubTimestamp":1777671074,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，辰欣药业报收于15.55元，较上周的15.31元上涨1.57%。本周，辰欣药业4月29日盘中最高价报15.79元。股本股东变化股东户数变动截至2026年3月31日，辰欣药业股东户数为4.21万户，较12月31日减少3079.0户，减幅为6.82%。公司公告汇总辰欣药业股份有限公司第五届董事会第十三次会议决议公告辰欣药业股份有限公司于2026年4月28日召开第五届董事会第十三次会议，审议通过《关于公司2026年第一季度报告的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631452085","title":"辰欣药业（603367）2026年一季报简析：净利润同比下降8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631452085","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631452085?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:17","pubTimestamp":1777501038,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期辰欣药业发布2026年一季报。根据财报显示，辰欣药业净利润同比下降8.92%。截至本报告期末，公司营业总收入8.5亿元，同比下降7.59%，归母净利润1.31亿元，同比下降8.92%。去年的净利率为12.36%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000019609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630373990","title":"辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630373990","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630373990?lang=zh_cn&edition=full","pubTime":"2026-04-28 15:51","pubTimestamp":1777362682,"startTime":"0","endTime":"0","summary":"智通财经APP讯，辰欣药业(603367.SH)发布2026年第一季度报告，第一季度，公司实现营业收入8.5亿元，同比下降7.59%。归属于上市公司股东的净利润1.31亿元，同比下降8.92%。归属于上市公司股东的扣除非经常性损益的净利润1.17亿元，同比增长0.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"530716c61aaa22cfcffdb04a123fa588","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"辰欣药业(603367.SH)发布一季度业绩，归母净利润1.31亿元，同比下降8.92%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628075980","title":"每周股票复盘：辰欣药业（603367）股东减持136.83万股完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2628075980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628075980?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:21","pubTimestamp":1776536467,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，辰欣药业报收于16.02元，较上周的16.34元下跌1.96%。本周，辰欣药业4月15日盘中最高价报16.65元。本周关注点股本股东变化：江苏辰昕同泰减持136.83万股，占总股本0.3022%，计划实施完毕。公司公告汇总辰欣药业股份有限公司股东减持计划实施完毕暨股份减持结果公告本次减持计划实施前，江苏辰昕同泰企业管理有限公司持有辰欣药业股份1,368,286股，占总股本的0.302%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627295074","title":"辰欣药业（603367）披露股东减持计划实施完毕公告，4月16日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627295074","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627295074?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:27","pubTimestamp":1776331634,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，辰欣药业报收于16.35元，较前一交易日下跌0.37%，最新总市值为74.03亿元。该股当日开盘16.31元，最高16.39元，最低16.13元，成交额达1.25亿元，换手率为1.7%。公告显示，本次减持计划实施前，江苏辰昕同泰企业管理有限公司持有辰欣药业股份1,368,286股，占总股本的0.302%。截至2026年4月14日，江苏辰昕通过集中竞价方式累计减持1,368,286股，占公司总股本的0.302%，减持计划已实施完毕。本次实际减持情况与此前披露的减持计划一致，未违反相关承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627407397","title":"4月15日辰欣药业发布公告，股东减持136.83万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627407397","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627407397?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:01","pubTimestamp":1776243690,"startTime":"0","endTime":"0","summary":"证券之星消息，4月15日辰欣药业发布公告《辰欣药业:辰欣药业股份有限公司股东减持计划实施完毕暨股份减持结果公告》，其股东江苏辰昕同泰企业管理有限公司于2026年4月8日至2026年4月14日间合计减持136.83万股，占公司目前总股本的0.3022%，变动期间该股股价下跌0.73%，截止4月14日收盘报16.22元。股东增减持详情见下表：根据辰欣药业2025年年报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624466228","title":"辰欣药业（603367）2025年年报简析：净利润同比下降17.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624466228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624466228?lang=zh_cn&edition=full","pubTime":"2026-04-04 06:02","pubTimestamp":1775253746,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期辰欣药业发布2025年年报。根据财报显示，辰欣药业净利润同比下降17.22%。截至本报告期末，公司营业总收入34.45亿元，同比下降13.48%，归母净利润4.21亿元，同比下降17.22%。按单季度数据看，第四季度营业总收入8.61亿元，同比下降12.09%，第四季度归母净利润3923.71万元，同比下降64.58%。该数据低于大多数分析师的预期，此前分析师普遍预期2025年净利润为盈利6.48亿元左右。去年的净利率为12.36%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040400002562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624577585","title":"辰欣药业最新公告：2025年度净利润4.21亿元同比下降17.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624577585","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624577585?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:29","pubTimestamp":1775122184,"startTime":"0","endTime":"0","summary":"辰欣药业(603367.SH)公告称，公司发布2025年年度报告，实现营业收入34.45亿元，同比下降13.48%；归属于上市公司股东的净利润为4.21亿元，同比下降17.22%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200030255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621151089","title":"股市必读：辰欣药业（603367）3月23日收盘跌5.52%，主力净流出565.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621151089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621151089?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:19","pubTimestamp":1774293595,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，辰欣药业报收于15.23元，下跌5.52%，换手率1.91%，成交量8.64万手，成交额1.34亿元。来自交易信息汇总：当日主力资金净流出565.56万元，占总成交额4.24%。交易信息汇总股价提醒3月23日辰欣药业收盘报15.23元，跌5.52%，当日成交864.06万元。根据收盘数据统计，该股已连续3日下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619245610","title":"辰欣药业（603367）披露股东减持股份计划公告，3月16日股价下跌0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619245610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619245610?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:21","pubTimestamp":1773652917,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，辰欣药业报收于17.0元，较前一交易日下跌0.53%，最新总市值为76.97亿元。该股当日开盘17.06元，最高17.15元，最低16.91元，成交额达6351.72万元，换手率为0.83%。辰欣药业股份有限公司于近日披露《股东减持股份计划公告》。本次减持计划将遵守相关法律法规规定，不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600023931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619120281","title":"每周股票复盘：辰欣药业（603367）股东拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619120281","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619120281?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:20","pubTimestamp":1773512424,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，辰欣药业报收于17.09元，较上周的16.98元上涨0.65%。本周，辰欣药业3月11日盘中最高价报17.4元。公司公告汇总辰欣药业股份有限公司股东江苏辰昕同泰企业管理有限公司计划自2026年4月7日至2026年7月7日，通过集中竞价或大宗交易方式减持公司股份不超过1,368,286股，占公司总股本比例不超过1%。本次减持原因为资金需求，股份来源为辰欣科技集团分立所得。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619319449","title":"辰欣药业最新公告：股东江苏辰昕拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619319449","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619319449?lang=zh_cn&edition=full","pubTime":"2026-03-13 19:59","pubTimestamp":1773403169,"startTime":"0","endTime":"0","summary":"辰欣药业(603367.SH)公告称，股东江苏辰昕同泰企业管理有限公司拟自2026年4月7日至2026年7月7日，通过集中竞价或大宗交易方式减持不超过1,368,286股，占公司总股本不超过1%；股份来源为辰欣科技集团分立所分配股份；减持原因为资金需求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300036430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601360735","title":"辰欣药业（603367）披露关于股东股份解除质押的公告，1月8日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360735","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601360735?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:20","pubTimestamp":1767882028,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，辰欣药业报收于18.43元，较前一交易日上涨0.88%，最新总市值为83.44亿元。该股当日开盘18.29元，最高18.6元，最低18.26元，成交额达2.03亿元，换手率为2.44%。公司近日发布公告称，股东韩延振持有辰欣药业股份21,269,329股，占公司总股本的4.698%。本次解除质押股份11,340,000股，占其所持股份的53.32%，占公司总股本的2.50%。本次解除质押后，韩延振剩余被质押股份为0股。公司于2026年1月8日收到相关通知，解除质押手续已办理完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800038934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601160005","title":"1月5日辰欣药业涨5.14%，富国新活力灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601160005","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601160005?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:33","pubTimestamp":1767598417,"startTime":"0","endTime":"0","summary":"重仓辰欣药业的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国新活力灵活配置混合A。吴栋栋在任的基金产品包括:富国质量成长6个月持有混合A，管理时间为2022年2月28日至今，期间收益率为50.66%；富国核心优势混合发起式A，管理时间为2023年12月1日至今，期间收益率为84.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585468278","title":"11月24日辰欣药业现5笔大宗交易 机构净买入2997.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585468278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585468278?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:59","pubTimestamp":1763978396,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日辰欣药业发生大宗交易，交易数据如下：近三个月该股共发生5笔大宗交易，合计成交2.43万手，折价成交5笔。该股近期无解禁股上市。截至2025年11月24日收盘，辰欣药业(603367)报收于18.36元，上涨0.33%，换手率2.94%，成交量13.33万手，成交额2.44亿元。该股近半年内有股东持股变动，合计净减持2158.52万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585084271","title":"每周股票复盘：辰欣药业（603367）股东一致行动人更名不涉股权变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2585084271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585084271?lang=zh_cn&edition=full","pubTime":"2025-11-23 01:39","pubTimestamp":1763833148,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，辰欣药业报收于18.3元，较上周的21.62元下跌15.36%。本周关注点公司公告汇总：股东一致行动人变更名称、注册地址及经营范围，不涉及持股数量及比例变动。公司公告汇总辰欣药业股份有限公司接到持股5%以上股东韩延振的一致行动人通知，原名为南京辰昕同泰创业投资有限公司的企业已更名为江苏辰昕同泰企业管理有限公司，并完成注册地址和经营范围变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584020183","title":"11月20日辰欣药业创60日新低，富国新活力灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584020183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584020183?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:32","pubTimestamp":1763623978,"startTime":"0","endTime":"0","summary":"重仓辰欣药业的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国新活力灵活配置混合A。吴栋栋在任的基金产品包括:富国质量成长6个月持有混合A，管理时间为2022年2月28日至今，期间收益率为38.87%；富国核心优势混合发起式A，管理时间为2023年12月1日至今，期间收益率为69.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000017682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779002468562,"stockEarnings":[{"period":"1week","weight":-0.0542},{"period":"1month","weight":-0.0969},{"period":"3month","weight":-0.1359},{"period":"6month","weight":-0.3145},{"period":"1year","weight":0.122},{"period":"ytd","weight":-0.1443}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辰欣药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42064人(较上一季度减少6.82%)","perCapita":"10763股","listingDate":"2017-09-29","address":"山东省济宁市任城区高新区同济科技工业园","registeredCapital":"45275万元","survey":" 辰欣药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是大容量注射剂、小容量注射剂、口服固体制剂、冻干粉针剂、冲洗剂、滴剂、膏剂、原料（自产外销）。公司是中国化学制药工业百强企业和山东省首批“十强”产业集群领军企业。","listedPrice":11.66},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辰欣药业(603367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辰欣药业(603367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辰欣药业,603367,辰欣药业股票,辰欣药业股票老虎,辰欣药业股票老虎国际,辰欣药业行情,辰欣药业股票行情,辰欣药业股价,辰欣药业股市,辰欣药业股票价格,辰欣药业股票交易,辰欣药业股票购买,辰欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辰欣药业(603367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辰欣药业(603367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}